Improving Care

Reducing morbidity and mortality and enhancing quality of life

Informing Policy

Transforming health care at the local, national and international levels

Featured Projects

With more than 80 scientists, research at Advancing Health encompasses a wide breadth of areas


The Evidence Speaks

A recurring feature highlighting the latest in Advancing Health research

Our People

In the News

Research Resources

From design to execution, Advancing Health provides a broad range of support services

Work in Progress Seminar Series

Nadia Khan

Scientist, MD, M.SC.

Dr. Nadia Khan is a Clinician Scientist in the field of clinical epidemiology and health services research at CHÉOS and the University of British Columbia (UBC).

Research Interests

  • Ethnic and gender differences in chronic disease incidence and outcomes
  • Chronic disease prevention and management of Type 2 diabetes, hypertension, stroke, and cardiovascular disease
  • Hypertension outcomes research

She is a specialist in internal medicine and a clinical specialist in hypertension by the American Society of Hypertension.

She was elected President of Hypertension Canada (2016-2020) and is the lead for the Research and Education Committee at the International Society of Hypertension.

Research areas of focus include investigation of cardiovascular risk factors and chronic disease prevention and management focusing on hypertension, in vulnerable populations including women and ethnic groups. Dr. Khan is completing a randomized controlled trial (Namaste Diabetes trial) to investigate culturally tailored interventions in the management of chronic cardiovascular disease and its risk factors in ethnic groups.

Publications of Note

Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial)

Sex differences in prodromal symptoms in acute coronary syndrome in patients aged 55 years or younger